Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 2/2021

Open Access 24.03.2021 | Review Article

Helicobacter pylori Infection Mass Screening for Children and Adolescents: a Systematic Review of Observational Studies

verfasst von: Hiroaki Saito, Yoshitaka Nishikawa, Yuko Masuzawa, Masaharu Tsubokura, Yasuhiro Mizuno

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Population-based Helicobacter pylori (H. pylori) screening and eradication for adults in areas with a high incidence of gastric cancer have been shown to be effective. The current status of H. pylori screening for young people, however, has not been sufficiently evaluated.

Methods

A systematic review of population-based H. pylori screening of young people was performed using four databases (MEDLINE, EMBASE, the Cochrane Library, and ICHUSHI) and independently evaluated by two investigators. Studies were evaluated with regard to the country, region, screening method, target age, number of screened people, and rate of positive screening.

Results

From 3231 studies, 39 studies were included (14 English original studies published in peer-review journals, 6 Japanese original studies, and 19 conference reports). These studies originated from 10 countries, with the largest number stemming from Japan (29 studies) followed by Germany (2 studies). Screening was performed using the urea breath test, blood antibodies, stool antigens, and urine antibodies. Five countries used the breath test as the first screening method, five used blood samples, two used stool antigens, and only Japan used urinary tests.

Conclusion

Screening for H. pylori in young people was reviewed based on reports from several countries, and findings suggest that local authorities considering screening for H. pylori in young people need to scrutinize the age and potential methods. Further research is required to determine the effectiveness of mid- to long-term H. pylori screening for young people.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Moyer VA: Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013;159(5):349–7. Moyer VA: Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013;159(5):349–7.
2.
Zurück zum Zitat Jankowski P, Banach M, Małyszko J, Mastej M, Tykarski A, Narkiewicz K, Hoffman P, Nowicki MP, Tomasik T, Windak A, et al. May measurement month 2018: an analysis of blood pressure screening campaign results from Poland. European heart journal supplements : journal of the European Society of Cardiology. 2020;22(Suppl H):H108-h111.CrossRef Jankowski P, Banach M, Małyszko J, Mastej M, Tykarski A, Narkiewicz K, Hoffman P, Nowicki MP, Tomasik T, Windak A, et al. May measurement month 2018: an analysis of blood pressure screening campaign results from Poland. European heart journal supplements : journal of the European Society of Cardiology. 2020;22(Suppl H):H108-h111.CrossRef
3.
Zurück zum Zitat Siu AL, Force USPST: Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2016;164(4):279–6. Siu AL, Force USPST: Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2016;164(4):279–6.
4.
Zurück zum Zitat White A, Thompson TD, White MC, Sabatino SA, de Moor J, Doria-Rose PV, Geiger AM, Richardson LC. Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66(8):201–6.PubMedPubMedCentralCrossRef White A, Thompson TD, White MC, Sabatino SA, de Moor J, Doria-Rose PV, Geiger AM, Richardson LC. Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66(8):201–6.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Yoon C, Dowdy DW, Esmail H, MacPherson P, Schumacher SG. Screening for tuberculosis: time to move beyond symptoms. Lancet Respir Med. 2019;7(3):202–4.PubMedPubMedCentralCrossRef Yoon C, Dowdy DW, Esmail H, MacPherson P, Schumacher SG. Screening for tuberculosis: time to move beyond symptoms. Lancet Respir Med. 2019;7(3):202–4.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Kahn JG, Bendavid E, Dietz PM, Hutchinson A, Horvath H, McCabe D, Wolitski RJ. Potential contributions of clinical and community testing in identifying persons with undiagnosed HIV infection in the United States. Journal of the International Association of Providers of AIDS Care. 2020;19:2325958220950902.PubMedPubMedCentralCrossRef Kahn JG, Bendavid E, Dietz PM, Hutchinson A, Horvath H, McCabe D, Wolitski RJ. Potential contributions of clinical and community testing in identifying persons with undiagnosed HIV infection in the United States. Journal of the International Association of Providers of AIDS Care. 2020;19:2325958220950902.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat An Q, Bernstein KT, Balaji AB, Wejnert C. Sexually transmitted infection screening and diagnosis among adolescent men who have sex with men, three US cities, 2015. Int J STD AIDS. 2020;31(1):53–61.PubMedCrossRef An Q, Bernstein KT, Balaji AB, Wejnert C. Sexually transmitted infection screening and diagnosis among adolescent men who have sex with men, three US cities, 2015. Int J STD AIDS. 2020;31(1):53–61.PubMedCrossRef
8.
Zurück zum Zitat Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9.PubMedCrossRef Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9.PubMedCrossRef
9.
Zurück zum Zitat Liu Z, Shi O, Zhang T, Jin L, Chen X: Disease burden of viral hepatitis A, B, C and E: a systematic analysis. J Viral Hepat. 2020;27(12):1284–1296. Liu Z, Shi O, Zhang T, Jin L, Chen X: Disease burden of viral hepatitis A, B, C and E: a systematic analysis. J Viral Hepat. 2020;27(12):1284–1296.
10.
Zurück zum Zitat Jee B, Yadav R, Pankaj S, Shahi SK: Immunology of HPV-mediated cervical cancer: current understanding. Int Rev Immunol. 2020:1–20. Jee B, Yadav R, Pankaj S, Shahi SK: Immunology of HPV-mediated cervical cancer: current understanding. Int Rev Immunol. 2020:1–20.
11.
Zurück zum Zitat Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114(6):1169–79.PubMedCrossRef Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114(6):1169–79.PubMedCrossRef
12.
Zurück zum Zitat Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol. 1999;94(9):2373–9.PubMedCrossRef Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol. 1999;94(9):2373–9.PubMedCrossRef
13.
Zurück zum Zitat Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325(16):1132–6.PubMedCrossRef Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325(16):1132–6.PubMedCrossRef
14.
Zurück zum Zitat Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085–95.PubMedCrossRef Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085–95.PubMedCrossRef
15.
Zurück zum Zitat Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113-1124.e1115.PubMedCrossRef Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113-1124.e1115.PubMedCrossRef
16.
Zurück zum Zitat Ford AC, Yuan Y, Forman D, Hunt R, Moayyedi P. Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev. 2020;7(7):Cd005583. Ford AC, Yuan Y, Forman D, Hunt R, Moayyedi P. Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev. 2020;7(7):Cd005583.
17.
Zurück zum Zitat Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: is it needed? Gastrointest Endosc. 2016;84(1):18–28.PubMedCrossRef Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: is it needed? Gastrointest Endosc. 2016;84(1):18–28.PubMedCrossRef
18.
Zurück zum Zitat Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol. 2008;103(3):510–4.PubMedCrossRef Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol. 2008;103(3):510–4.PubMedCrossRef
19.
Zurück zum Zitat Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, et al. Management of Helicobacter pylori infection—the Maastricht IV/ Florence consensus report. Gut. 2012;61(5):646–64.PubMedCrossRef Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, et al. Management of Helicobacter pylori infection—the Maastricht IV/ Florence consensus report. Gut. 2012;61(5):646–64.PubMedCrossRef
20.
Zurück zum Zitat Yamaguchi Y, Nagata Y, Hiratsuka R, Kawase Y, Tominaga T, Takeuchi S, Sakagami S, Ishida S. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels—the ABC method. Digestion. 2016;93(1):13–8.PubMedCrossRef Yamaguchi Y, Nagata Y, Hiratsuka R, Kawase Y, Tominaga T, Takeuchi S, Sakagami S, Ishida S. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels—the ABC method. Digestion. 2016;93(1):13–8.PubMedCrossRef
21.
Zurück zum Zitat Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16(Suppl 1):1–9.PubMedPubMedCentralCrossRef Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16(Suppl 1):1–9.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Ünlüsoy Aksu A, Yılmaz G, Eğritaş Gürkan Ö, Sarı S, Dalgıç B. The effect of Helicobacter pylori eradication on functional dyspepsia in Turkish children. Helicobacter. 2018;23(4):e12497.PubMedCrossRef Ünlüsoy Aksu A, Yılmaz G, Eğritaş Gürkan Ö, Sarı S, Dalgıç B. The effect of Helicobacter pylori eradication on functional dyspepsia in Turkish children. Helicobacter. 2018;23(4):e12497.PubMedCrossRef
23.
Zurück zum Zitat Lahaie RG, Gaudreau C: Helicobacter pylori antibiotic resistance: trends over time. Can J Gastroenterol = Journal Canadien de Gastroenterologie. 2000;14(10):895–9. Lahaie RG, Gaudreau C: Helicobacter pylori antibiotic resistance: trends over time. Can J Gastroenterol = Journal Canadien de Gastroenterologie. 2000;14(10):895–9.
24.
Zurück zum Zitat Eusebi LH, Telese A, Marasco G, Bazzoli F, Zagari RM. Gastric cancer prevention strategies: a global perspective. J Gastroenterol Hepatol. 2020;35(9):1495–1502. Eusebi LH, Telese A, Marasco G, Bazzoli F, Zagari RM. Gastric cancer prevention strategies: a global perspective. J Gastroenterol Hepatol. 2020;35(9):1495–1502.
25.
Zurück zum Zitat Suzuki H, Mori H. Helicobacter pylori: Helicobacter pylori gastritis—a novel distinct disease entity. Nat Rev Gastroenterol Hepatol. 2015;12(10):556–7.PubMedCrossRef Suzuki H, Mori H. Helicobacter pylori: Helicobacter pylori gastritis—a novel distinct disease entity. Nat Rev Gastroenterol Hepatol. 2015;12(10):556–7.PubMedCrossRef
26.
Zurück zum Zitat Akamatsu T, Ichikawa S, Okudaira S, Yokosawa S, Iwaya Y, Suga T, Ota H, Tanaka E. Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening. J Gastroenterol. 2011;46(12):1353–60.PubMedCrossRef Akamatsu T, Ichikawa S, Okudaira S, Yokosawa S, Iwaya Y, Suga T, Ota H, Tanaka E. Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening. J Gastroenterol. 2011;46(12):1353–60.PubMedCrossRef
27.
Zurück zum Zitat Szaflarska-Popławska A, Soroczyńska-Wrzyszcz A. Prevalence of Helicobacter pylori infection among junior high school students in Grudziadz, Poland. Helicobacter. 2019;24(1):e12552. Szaflarska-Popławska A, Soroczyńska-Wrzyszcz A. Prevalence of Helicobacter pylori infection among junior high school students in Grudziadz, Poland. Helicobacter. 2019;24(1):e12552.
28.
Zurück zum Zitat Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter. 2007;12(4):333–40.PubMedCrossRef Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter. 2007;12(4):333–40.PubMedCrossRef
29.
Zurück zum Zitat Hestvik E, Tylleskar T, Kaddu-Mulindwa DH, Ndeezi G, Grahnquist L, Olafsdottir E, Tumwine JK. Helicobacter pylori in apparently healthy children aged 0–12 years in urban Kampala, Uganda: a community-based cross sectional survey. BMC Gastroenterol. 2010;10:62.PubMedPubMedCentralCrossRef Hestvik E, Tylleskar T, Kaddu-Mulindwa DH, Ndeezi G, Grahnquist L, Olafsdottir E, Tumwine JK. Helicobacter pylori in apparently healthy children aged 0–12 years in urban Kampala, Uganda: a community-based cross sectional survey. BMC Gastroenterol. 2010;10:62.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Mohammad MA, Hussein L, Coward A, Jackson SJ. Prevalence of Helicobacter pylori infection among Egyptian children: Impact of social background and effect on growth. Public Health Nutr. 2008;11(3):230–6.PubMedCrossRef Mohammad MA, Hussein L, Coward A, Jackson SJ. Prevalence of Helicobacter pylori infection among Egyptian children: Impact of social background and effect on growth. Public Health Nutr. 2008;11(3):230–6.PubMedCrossRef
31.
Zurück zum Zitat Dattoli VC, Veiga RV, da Cunha SS, Pontes-de-Carvalho LC, Barreto ML, Alcantara-Neves NM. Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children. Helicobacter. 2010;15(4):273–8.PubMedPubMedCentralCrossRef Dattoli VC, Veiga RV, da Cunha SS, Pontes-de-Carvalho LC, Barreto ML, Alcantara-Neves NM. Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children. Helicobacter. 2010;15(4):273–8.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Tam YH, Yeung CK, Lee KH, Sihoe JDY, Chan KW, Cheung ST, Mou JWC. A population-based study of Helicobacter pylori infection in Chinese children resident in Hong Kong: prevalence and potential risk factors. Helicobacter. 2008;13(3):219–24.PubMedCrossRef Tam YH, Yeung CK, Lee KH, Sihoe JDY, Chan KW, Cheung ST, Mou JWC. A population-based study of Helicobacter pylori infection in Chinese children resident in Hong Kong: prevalence and potential risk factors. Helicobacter. 2008;13(3):219–24.PubMedCrossRef
33.
Zurück zum Zitat Salomaa-Rasanen A, Kosunen TU, Aromaa AR, Knekt P, Sarna S, Rautelin H. A “screen-and-treat” approach for Helicobacter pylori infection: a population-based study in Vammala. Finland Helicobacter. 2010;15(1):28–37.PubMedCrossRef Salomaa-Rasanen A, Kosunen TU, Aromaa AR, Knekt P, Sarna S, Rautelin H. A “screen-and-treat” approach for Helicobacter pylori infection: a population-based study in Vammala. Finland Helicobacter. 2010;15(1):28–37.PubMedCrossRef
34.
Zurück zum Zitat Rothenbacher D, Bode G, Berg G, Knayer U, Gonser T, Adler G, Brenner H. Helicobacter pylori among preschool children and their parents: evidence of parent-child transmission. J Infect Dis. 1999;179(2):398–402.PubMedCrossRef Rothenbacher D, Bode G, Berg G, Knayer U, Gonser T, Adler G, Brenner H. Helicobacter pylori among preschool children and their parents: evidence of parent-child transmission. J Infect Dis. 1999;179(2):398–402.PubMedCrossRef
35.
Zurück zum Zitat Bode G, Rothenbacher D, Brenner H, Adler G. Helicobacter pylori and abdominal symptoms: a population-based study among preschool children in Southern Germany. Pediatrics. 1998;101(4):634–7.PubMedCrossRef Bode G, Rothenbacher D, Brenner H, Adler G. Helicobacter pylori and abdominal symptoms: a population-based study among preschool children in Southern Germany. Pediatrics. 1998;101(4):634–7.PubMedCrossRef
36.
Zurück zum Zitat Dominici P, Bellentani S, Di BAR, Saccoccio G, Le RA, Masutti F, Viola L, Balli F, Tiribelli C, Grilli R, et al. Familial clustering of Helicobacter pylori infection: population based study. Br Med J. 1999;319(7209):537–41.CrossRef Dominici P, Bellentani S, Di BAR, Saccoccio G, Le RA, Masutti F, Viola L, Balli F, Tiribelli C, Grilli R, et al. Familial clustering of Helicobacter pylori infection: population based study. Br Med J. 1999;319(7209):537–41.CrossRef
37.
Zurück zum Zitat Honma H, Nakayama Y, Kato S, Hidaka N, Kusakari M, Sado T, Suda A, Lin Y: Clinical features of Helicobacter pylori antibody-positive junior high school students in Nagano Prefecture, Japan. Helicobacter. 2018:e12559. Honma H, Nakayama Y, Kato S, Hidaka N, Kusakari M, Sado T, Suda A, Lin Y: Clinical features of Helicobacter pylori antibody-positive junior high school students in Nagano Prefecture, Japan. Helicobacter. 2018:e12559.
38.
Zurück zum Zitat Akamatsu T, Okamura T, Iwaya Y, Suga T. Screening to identify and eradicate Helicobacter pylori infection in teenagers in Japan. Gastroenterol Clin North Am. 2015;44(3):667–76.PubMedCrossRef Akamatsu T, Okamura T, Iwaya Y, Suga T. Screening to identify and eradicate Helicobacter pylori infection in teenagers in Japan. Gastroenterol Clin North Am. 2015;44(3):667–76.PubMedCrossRef
39.
Zurück zum Zitat Kusano C, Gotoda T, Suzuki S, Ikehara H. The administrative project of Helicobacter pylori infection screening among junior high school students in an area of Japan with a high incidence of gastric cancer. Gut. 2018;67:A43–4. Kusano C, Gotoda T, Suzuki S, Ikehara H. The administrative project of Helicobacter pylori infection screening among junior high school students in an area of Japan with a high incidence of gastric cancer. Gut. 2018;67:A43–4.
40.
Zurück zum Zitat Okuda M, Tachikawa T, Osaki Y, Maekawa K. Focusing on examination and diagnosis of Helicobacter pylori in junior high school students in Sasayama City (in Japanese). The Journal of the Japan Pediatric Society. 2014;118(2):326. Okuda M, Tachikawa T, Osaki Y, Maekawa K. Focusing on examination and diagnosis of Helicobacter pylori in junior high school students in Sasayama City (in Japanese). The Journal of the Japan Pediatric Society. 2014;118(2):326.
41.
Zurück zum Zitat Okamura T, Suga T, Yokosawa S, Niikura N, Matsumoto T, Okudaira S, Akamatsu T, Tanaka E. Introduction of H. pylori screening into routine school medical examinations (in Japanese). Jpn J Helicobacter Res. 2015;16(2):10–15. Okamura T, Suga T, Yokosawa S, Niikura N, Matsumoto T, Okudaira S, Akamatsu T, Tanaka E. Introduction of H. pylori screening into routine school medical examinations (in Japanese). Jpn J Helicobacter Res. 2015;16(2):10–15.
42.
Zurück zum Zitat Shinichi F, Mutsuko K, Nariaki T, Michiko T, Shinichi Y. A study on the prevalence of Helicobacter pylori infection in children in urban and rural areas (in Japanese). The Mutual Aid Examiner Newsletter. 2015;37:25–9. Shinichi F, Mutsuko K, Nariaki T, Michiko T, Shinichi Y. A study on the prevalence of Helicobacter pylori infection in children in urban and rural areas (in Japanese). The Mutual Aid Examiner Newsletter. 2015;37:25–9.
43.
Zurück zum Zitat Sasaki Y, Yuichi A, Yukari Y, Hiroki K. Helicobacter pylori screening in junior high school students in Abashiri City] (in Japanese). J Clin Pediatr, Sapporo. 2017;65(1–6):21–4. Sasaki Y, Yuichi A, Yukari Y, Hiroki K. Helicobacter pylori screening in junior high school students in Abashiri City] (in Japanese). J Clin Pediatr, Sapporo. 2017;65(1–6):21–4.
44.
Zurück zum Zitat Kousen K, Miyamura T, Ogasawara M, Mabe K, Kato M. Helicobacter pylori screening for junior high school students (first report) as a medical association project with the aim of eradicating gastric cancer in the area (in Japanese). J Med Assoc South Hokkaido. 2018;Supplement 1. Kousen K, Miyamura T, Ogasawara M, Mabe K, Kato M. Helicobacter pylori screening for junior high school students (first report) as a medical association project with the aim of eradicating gastric cancer in the area (in Japanese). J Med Assoc South Hokkaido. 2018;Supplement 1.
45.
Zurück zum Zitat Handa O. Medical trends Kyoto First year high school pylori project (in Japanese). Schneller. 2018;106:8–12. Handa O. Medical trends Kyoto First year high school pylori project (in Japanese). Schneller. 2018;106:8–12.
46.
Zurück zum Zitat Ichikawa S, Akamatsu T, Okudaira S. Selection and expansion of H. pylori eradication therapy. Introduction of Helicobacter pylori infection screening tests in school screening (in Japanese). Gastroenterology. 2009;48(1):1–5. Ichikawa S, Akamatsu T, Okudaira S. Selection and expansion of H. pylori eradication therapy. Introduction of Helicobacter pylori infection screening tests in school screening (in Japanese). Gastroenterology. 2009;48(1):1–5.
47.
Zurück zum Zitat Akifuji Y, Amano M, Okamoto T, Takami H, Miyakawa T, Kawamoto T, Tsukuda S, Igori J, Ootani M: Helicobacter pylori screening for primary prevention of gastric cancer in junior high school students in Hokuei Town, Tottori Prefecture, Japan (first report) (in Japanese). In: Tottori Medical Association Spring Medical Conference. 2016. Akifuji Y, Amano M, Okamoto T, Takami H, Miyakawa T, Kawamoto T, Tsukuda S, Igori J, Ootani M: Helicobacter pylori screening for primary prevention of gastric cancer in junior high school students in Hokuei Town, Tottori Prefecture, Japan (first report) (in Japanese). In: Tottori Medical Association Spring Medical Conference. 2016.
48.
Zurück zum Zitat Kaji E, Yoda A, Aomatsu T, Okudaira T, Akamatsu M, Tamai H: How Helicobacter pylori screening and eradication for the prevention of gastric cancer in junior high school students: Takatsuki-shi pediatric H. pylori study (2014) (in Japanese). J Jpn Pediatr Soc. 2016;120(2):208. Kaji E, Yoda A, Aomatsu T, Okudaira T, Akamatsu M, Tamai H: How Helicobacter pylori screening and eradication for the prevention of gastric cancer in junior high school students: Takatsuki-shi pediatric H. pylori study (2014) (in Japanese). J Jpn Pediatr Soc. 2016;120(2):208.
49.
Zurück zum Zitat Ota Y, Otsuka T, Tomidokoro T. Examination of H. pylori in junior high school students in Nagaoka City (in Japanese). J Jpn Pediatr Soc. 2018, 122(8):1379–1380 Ota Y, Otsuka T, Tomidokoro T. Examination of H. pylori in junior high school students in Nagaoka City (in Japanese). J Jpn Pediatr Soc. 2018, 122(8):1379–1380
50.
Zurück zum Zitat Okuda M. Diagnosis and treatment of Helicobacter pylori infection in childhood—toward screening and eradication of Helicobacter pylori in junior and senior high school students for prevention of gastric cancer (in Japanese). Bulletin of the Osaka Pediatricians’ Association. 2015;172:26–7. Okuda M. Diagnosis and treatment of Helicobacter pylori infection in childhood—toward screening and eradication of Helicobacter pylori in junior and senior high school students for prevention of gastric cancer (in Japanese). Bulletin of the Osaka Pediatricians’ Association. 2015;172:26–7.
51.
Zurück zum Zitat Okuda M, Kikuchi S, Mabe K, Kato M. [How should junior high school students be screened for Helicobacter pylori and eradicated to prevent gastric cancer? Screening and eradication of Helicobacter pylori in junior high school students for the prevention of gastric cancer Including the initiatives of Sasayama City and a nationwide survey](in Japanese). The Journal of the Japan Pediatric Society. 2016;120(2):207. Okuda M, Kikuchi S, Mabe K, Kato M. [How should junior high school students be screened for Helicobacter pylori and eradicated to prevent gastric cancer? Screening and eradication of Helicobacter pylori in junior high school students for the prevention of gastric cancer Including the initiatives of Sasayama City and a nationwide survey](in Japanese). The Journal of the Japan Pediatric Society. 2016;120(2):207.
52.
Zurück zum Zitat Tachikawa T, Fujino E, Maekawa K, Okuda M, Fukuda Y, Fujino T, Ueda J, Kikuchi S. Screening for Helicobacter pylori in junior high school students in Sasayama City (in Japanese). The Journal of the Japan Pediatric Society. 2014;118(6):965. Tachikawa T, Fujino E, Maekawa K, Okuda M, Fukuda Y, Fujino T, Ueda J, Kikuchi S. Screening for Helicobacter pylori in junior high school students in Sasayama City (in Japanese). The Journal of the Japan Pediatric Society. 2014;118(6):965.
53.
Zurück zum Zitat Okamura t, Suga T, Niikura N. Introduction of screening for H. pylori infection to school screening and examination of pepsinogen levels in high school students in relation to strategies to reduce gastric cancer mortality (in Japanese). J Jpn Soc Gastroenterol. 2014;111:A720. Okamura t, Suga T, Niikura N. Introduction of screening for H. pylori infection to school screening and examination of pepsinogen levels in high school students in relation to strategies to reduce gastric cancer mortality (in Japanese). J Jpn Soc Gastroenterol. 2014;111:A720.
54.
Zurück zum Zitat Okuda M, Kikuchi S, Mabe K, Kato M, Fukuda Y. Screening for Helicobacter pylori and treatment for gastric cancer in junior high school students (in Japanese). J Jpn Soc Gastroenterol. 2014;111:A255. Okuda M, Kikuchi S, Mabe K, Kato M, Fukuda Y. Screening for Helicobacter pylori and treatment for gastric cancer in junior high school students (in Japanese). J Jpn Soc Gastroenterol. 2014;111:A255.
55.
Zurück zum Zitat Mabe K, Miyamoto S, Mizushima T, Ono M, Omori S, Ono S, Shimizu Y, Kato M, Asaka M: The strategy of test and treat for H. Pylori infection to junior and senior high school students in Hokkaido, Japan. Helicobacter. 2014;19:162. Mabe K, Miyamoto S, Mizushima T, Ono M, Omori S, Ono S, Shimizu Y, Kato M, Asaka M: The strategy of test and treat for H. Pylori infection to junior and senior high school students in Hokkaido, Japan. Helicobacter. 2014;19:162.
56.
Zurück zum Zitat Fujiwara S, Konno M, Hattori T, Doyama A, Tosaka N, Takahashi M. How Helicobacter pylori screening and eradication for the prevention of gastric cancer should be performed in junior high school students: a study of mass screening for H. pylori and eradication in Memuro-cho (in Japanese). J Jpn Pediatr Soc. 2016;120(2):207. Fujiwara S, Konno M, Hattori T, Doyama A, Tosaka N, Takahashi M. How Helicobacter pylori screening and eradication for the prevention of gastric cancer should be performed in junior high school students: a study of mass screening for H. pylori and eradication in Memuro-cho (in Japanese). J Jpn Pediatr Soc. 2016;120(2):207.
57.
Zurück zum Zitat Kakiuchi T, Nakayama A, Matsuo M. Helicobacter pylori “Program to promote measures against gastric cancer for the future” screening in all third-year junior high schools in Saga Prefecture (in Japanese). The general meeting of the Japanese Society of Gastroenterology. 2017;121(2):339. Kakiuchi T, Nakayama A, Matsuo M. Helicobacter pylori “Program to promote measures against gastric cancer for the future” screening in all third-year junior high schools in Saga Prefecture (in Japanese). The general meeting of the Japanese Society of Gastroenterology. 2017;121(2):339.
58.
Zurück zum Zitat Yamashita N, Inoue K, Ishii M, Imamura Y, Mabe N, Kamata T, Kusunoki H, Shioya A, Hatake J, Kondo H et al. Serum pepsinogen levels and ABC classification of H. pylori-positive junior high school students (in Japanese). Japan Gastroenterological Cancer Screening Congress. 2014;52(5):215. Yamashita N, Inoue K, Ishii M, Imamura Y, Mabe N, Kamata T, Kusunoki H, Shioya A, Hatake J, Kondo H et al. Serum pepsinogen levels and ABC classification of H. pylori-positive junior high school students (in Japanese). Japan Gastroenterological Cancer Screening Congress. 2014;52(5):215.
59.
Zurück zum Zitat Ichikawa S, Akamatsu T, Ito T, Sudo M, Yoneda S, Sudo T, Takeda R, Takenaka K, Nagaya M, Kitahara K et al. Introduction of Helicobacter pylori infection screening test in school screening-focusing on the results of secondary examinations (in Japanese). Gastroenterol Endosc. 2009;51:Page815. Ichikawa S, Akamatsu T, Ito T, Sudo M, Yoneda S, Sudo T, Takeda R, Takenaka K, Nagaya M, Kitahara K et al. Introduction of Helicobacter pylori infection screening test in school screening-focusing on the results of secondary examinations (in Japanese). Gastroenterol Endosc. 2009;51:Page815.
60.
Zurück zum Zitat Akamatsu T, Kaneko Y, Suzawa K. Expansion of indications for H. pylori eradication therapy (in Japanese). J Jpn Soc Gastroenterol 2008;100:A46. Akamatsu T, Kaneko Y, Suzawa K. Expansion of indications for H. pylori eradication therapy (in Japanese). J Jpn Soc Gastroenterol 2008;100:A46.
61.
Zurück zum Zitat Ono K, Handa K. Establishment of a screening system for junior high school students by Helicobacter pylori antibody testing (in Japanese). J Jpn Soc Gastroenterol. 2016;113:A699. Ono K, Handa K. Establishment of a screening system for junior high school students by Helicobacter pylori antibody testing (in Japanese). J Jpn Soc Gastroenterol. 2016;113:A699.
62.
Zurück zum Zitat Kitagawa K, Taguchi J: Helicobacter pylori screening in junior high school students (in Japanese). In: National Association for Regional Health Care. 2017. Kitagawa K, Taguchi J: Helicobacter pylori screening in junior high school students (in Japanese). In: National Association for Regional Health Care. 2017.
63.
Zurück zum Zitat Kusano C, Gotoda T, Suzuki S, Kono S, Iwatsuka K. Prevalence of Helicobacter pylori infection in children in an area of Japan with a high incidence of gastric cancer: a population-based cross-sectional study. Journal of Gastroenterology. 2016;150(4):S438.CrossRef Kusano C, Gotoda T, Suzuki S, Kono S, Iwatsuka K. Prevalence of Helicobacter pylori infection in children in an area of Japan with a high incidence of gastric cancer: a population-based cross-sectional study. Journal of Gastroenterology. 2016;150(4):S438.CrossRef
64.
Zurück zum Zitat Ichikawa S, Akamatsu T, Sudo T, Takeda R, Takenaka K, Nagaya M, Tanaka E. Introduction of screening test for Helicobacter pylori infection into school examinations Drug Resistance and Eradication Outcomes in Secondary Screening (in Japanese). J Jpn Soc Gastroenterol. 2009;106:A769. Ichikawa S, Akamatsu T, Sudo T, Takeda R, Takenaka K, Nagaya M, Tanaka E. Introduction of screening test for Helicobacter pylori infection into school examinations Drug Resistance and Eradication Outcomes in Secondary Screening (in Japanese). J Jpn Soc Gastroenterol. 2009;106:A769.
65.
Zurück zum Zitat Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2004;9(Suppl 1):1–6.PubMedCrossRef Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2004;9(Suppl 1):1–6.PubMedCrossRef
66.
Zurück zum Zitat Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997;40(3):297–301.PubMedPubMedCentralCrossRef Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997;40(3):297–301.PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995;87(23):1777–80.PubMedCrossRef Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995;87(23):1777–80.PubMedCrossRef
68.
Zurück zum Zitat Hudak L, Jaraisy A, Haj S, Muhsen K: An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter. 2017;22(1). Hudak L, Jaraisy A, Haj S, Muhsen K: An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter. 2017;22(1).
69.
Zurück zum Zitat Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60(10):1309–16.PubMedCrossRef Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60(10):1309–16.PubMedCrossRef
70.
Zurück zum Zitat Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30.PubMedCrossRef Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6–30.PubMedCrossRef
71.
Zurück zum Zitat Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, Czinn S, Gold BD, Guarner J, Elitsur Y, et al. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr. 2017;64(6):991–1003.PubMedCrossRef Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, Czinn S, Gold BD, Guarner J, Elitsur Y, et al. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr. 2017;64(6):991–1003.PubMedCrossRef
72.
Zurück zum Zitat Saito H, Nishikawa Y, Mizuno Y. Patient outcomes and environment may affect adherence to Helicobacter pylori testing. Clin Gastroenterol Hepatol. 2020; S1542-3565(20)30936-8. Saito H, Nishikawa Y, Mizuno Y. Patient outcomes and environment may affect adherence to Helicobacter pylori testing. Clin Gastroenterol Hepatol. 2020; S1542-3565(20)30936-8.
Metadaten
Titel
Helicobacter pylori Infection Mass Screening for Children and Adolescents: a Systematic Review of Observational Studies
verfasst von
Hiroaki Saito
Yoshitaka Nishikawa
Yuko Masuzawa
Masaharu Tsubokura
Yasuhiro Mizuno
Publikationsdatum
24.03.2021
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 2/2021
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-021-00630-0

Weitere Artikel der Ausgabe 2/2021

Journal of Gastrointestinal Cancer 2/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.